Brief: CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Collplant Biotechnologies

02/01/2024 12:18

Jan 2 (Reuters) - Collplant Biotechnologies Ltd
 CPTG.F :
    * COLLPLANT BIOTECHNOLOGIES BEGINS PRECLINICAL TRIAL WITH
COMMERCIAL-SIZE, REGENERATIVE BREAST IMPLANTS
    * COLLPLANT BIOTECHNOLOGIES LTD: EXPECTS STUDY TO CONCLUDE
BY
FIRST HALF OF 2024
    * COLLPLANT: PLANS TO USE FINDINGS FOR FURTHER OPTIMIZATION
OF
IMPLANT DESIGN TOWARDS GLP PRECLINICAL PIVOTAL STUDY WITH
COMMERCIAL SIZE IMPLANTS

Source text for Eikon:  ID:nPn7Yh8HJa 
Further company coverage:  CPTG.F 

 ((Reuters.Briefs@thomsonreuters.com;))